Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.

Cancer medicine - 1 Dec 2013

Craveiro Vinicius, Yang-Hartwich Yang, Holmberg Jennie C, Joo Won Duk, Sumi Natalia J, Pizzonia John, Griffin Brian, Gill Sabrina K, Silasi Dan-Arin, Azodi Masoud, Rutherford Thomas, Alvero Ayesha B, Mor Gil

Abstract excerpt

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Despite initial responsiveness, 80% of EOC patients recur and present with chemoresistant and a more aggressive disease. This suggests an underlying biology that results in a modified recurrent disease, which is distinct from the primary tumor. Unfortunately, the management of recurrent EOC is similar to primary disease and does not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Myeloid Differentiation Factor 88

Share to Neoplasms, Glandular and Epithelial

Share to Paclitaxel

Share to Snail Family Transcription Factors

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 24403249
DOI: 10.1002/cam4.115
PMCID: PMC3892380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.PMID 24403249Read ↗

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.Semantic proximity Read ↗

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.Semantic proximity Read ↗

A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunitiesSemantic proximity Read ↗

TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrenceSemantic proximity Read ↗

Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer.Semantic proximity Read ↗

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.Semantic proximity Read ↗

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and MetastasisSemantic proximity Read ↗

Chemoresistance is mediated by ovarian cancer leader cells in vitroSemantic proximity Read ↗

An Integrative Transcriptomic Analysis of a Stemness-Associated Gene Set on Ovarian Cancer RecurrenceSemantic proximity Read ↗

Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigmSemantic proximity Read ↗

Modeling platinum resistance in a stem-like patient-derived ovarian cancer sampleSemantic proximity Read ↗

Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovarySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.